Mesothelioma Cancer Resources Blog

Source: Annals of Thoracic and Cardiovascular Surgery In the article “Localized Malignant Mesothelioma of the Pleura,” published in the Annals of Thoracic and Cardiovascular Surgery, researchers from Japan describe the case of a 54 year-old man who presented with a pleural mass initially misdiagnosed as a benign pleural tumor. After growth of the tumor over …

 Source: Annals of Thoracic Surgery Aprotinin is a serine protease inhibitor used during surgery to constrain excess bleeding. Two previous studies on aprotinin have shown a reduction in blood loss during thoracic surgery and a decrease in the volume of blood needed for transfusions during surgery. The study being discussed here looked at the use …

Source: Wiley Interscience Occupational exposure is the most common type of exposure to asbestos. Workers in a variety of industries have respirated or otherwise “taken-in” asbestos due to the presence of the fibers in a number of products. It is because of this fiber intake that certain occupations have higher-rates of mesothelioma and other asbestos-caused …

Source: Wall Street Journal The Wall Street Journal has published an article on support groups and other wellness programs for cancer survivors. As more and more people are surviving cancer, there is concern that doctors and other medical professionals are not doing enough to support the psychological health of the survivors. Study after study has …

Source: PubMed.Com That asbestos exposure causes multiple pulmonary diseases has been conclusively known since at least the 1920s. What have remained in question are the physiological mechanisms by which exposure leads to disease and/or death. Researches from the EPA have recently studied the relationship between asbestos and iron homeostasis and have determined that one of …

Source: PubMed.Com One of the most common research programs in the study of malignant mesothelioma is the search for biomarkers that improve upon the ability of current methodologies to diagnosis mesothelioma. The study that is referenced here looked at the expression of VEGFR-3 (vascular endothelial growth factor receptor-3) in patients with mesothelioma generally and its …

Source: CancerPage.com A study on the benefits of vinflunine for the treatment of mesothelioma was published in the Journal of Clinical Oncology on October 20. Vinflunine is a microtubule inhibitor that is being studied for its therapeutic effects on a number of different cancers. This particular study was looking at the effects of vinflunine as …

Source: CancerConsultants.com At the 12th World Conference on Lung Cancer held in Seoul, South Korea researchers presented the results of two separate studies analyzing the effectiveness of Alimta® for the treatment of malignant mesothelioma. Researchers from Germany presented the results of an open-label study comparing Alimta alone to Alimta® + Platinol® (cisplatin) and to Alimta® …